Inventor · disambiguated record
Daniel A. Heller
Also filed as: HELLER DANIEL · HELLER DANIEL A · HELLER DANIEL ALEXANDER
10 granted patents·24 pending applications·14 citations·filing 2012–2022
83Inventor score
Files withMEMORIAL SLOAN KETTERING CANCER CENTER17TWO PORE GUYS INC8ONTERA INC6SLOAN KETTERING INST CANCER2NOOMA BIO INC1
Top patents by PatentIndex Score
34 records- 0186US10048245B2Multiplexed biomarker quantitation by nanopore analysis of biomarker-polymer complexesTWO PORE GUYS INC·Filed 2014·Granted Aug 14, 2018·7 cites·6 claims
- 0284US10670590B2Target detection with nanoporeONTERA INC·Filed 2016·Granted Jun 2, 2020·2 cites·17 claims
- 0384US10495628B2Multiplexed biomarker quantitation by nanopore analysis of biomarker-polymer complexesONTERA INC·Filed 2018·Granted Dec 3, 2019·2 cites·8 claims
- 0471US10478506B2Fucoidan nanogels and methods of their use and manufactureMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2019·Granted Nov 19, 2019·1 cites·20 claims
- 0571US2023114946A1Mesoscale nanoparticles for selective targeting to the kidney and methods of their therapeutic useMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2022·Application pending·0 cites
- 0670US11098348B2Nanopore detection of target polynucleotides from sample backgroundONTERA INC·Filed 2016·Granted Aug 24, 2021·1 cites·59 claims
- 0769US12429481B2Target detection with nanoporeONTERA INC·Filed 2020·Granted Sep 30, 2025·0 cites·19 claims
- 0868US9737614B2Fucoidan nanogels and methods of their use and manufactureMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2016·Granted Aug 22, 2017·1 cites·13 claims
- 0968US2020222333A1Mesoscale nanoparticles for selective targeting to the kidney and methods of their therapeutic useMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2019·Application pending·0 cites
- 1064US2022195501A1Targeted Sequence Detection by Nanopore Sensing of Synthetic ProbesNOOMA BIO INC·Filed 2022·Application pending·0 cites
- 1163US2021364507A1Swcnt-dna-antibody conjugates, related compositions, and systems, methods and devices for their useMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2021·Application pending·0 cites
- 1262US2022276171A1Composition and method for monitoring lipidMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2021·Application pending·0 cites
- 1361US2020237670A1Dye-stabilized nanoparticles and methods of their manufacture and therapeutic useMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2019·Application pending·0 cites
- 1458US11097019B2Helical polycarbodiimide polymers and associated imaging, diagnostic, and therapeutic methodsMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2018·Granted Aug 24, 2021·0 cites·14 claims
- 1558US2019383744A1Composition and method for monitoring lipidMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2019·Application pending·0 cites
- 1657US2021262017A1Sensors for nucleic acid biomarkersMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2020·Application pending·0 cites
- 1757US2019383806A9Target Detection with NanoporeONTERA INC·Filed 2016·Application pending·0 cites
- 1857US2018243227A1Mesoscale nanoparticles for selective targeting to the kidney and methods of their therapeutic useMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2016·Application pending·0 cites
- 1956US10871482B2Target detection with nanopore and a polymer scaffold complexONTERA INC·Filed 2016·Granted Dec 22, 2020·0 cites·21 claims
- 2051US2022257599A1Methods useful in treating cancers harboring a kras or hras mutation or amplificationMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2020·Application pending·0 cites
- 2151US2024009359A1Drug eluting elastic bands and ligationMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2021·Application pending·0 cites
- 2250US2019154670A1Swcnt-dna-antibody conjugates, related compositions, and systems, methods and devices for their useMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2017·Application pending·0 cites
- 2349US10401295B2Composition and method for monitoring lipidMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2015·Granted Sep 3, 2019·0 cites·1 claims
- 2448US2019119734A1Sensors for nucleic acid biomarkersMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2017·Application pending·0 cites
- 2548US2017349940A1Targeted Sequence Detection by Nanopore Sensing of Synthetic ProbesTWO PORE GUYS INC·Filed 2015·Application pending·0 cites
- 2647US2018021259A1Dye-stabilized nanoparticles and methods of their manufacture and therapeutic useMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2016·Application pending·0 cites
- 2744US2016067362A1Helical polycarbodiimide polymers and associated imaging, diagnostic, and therapeutic methodsSLOAN KETTERING INST CANCER·Filed 2015·Application pending·0 cites
- 2841US2015328254A1Fucoidan nanogels and methods of their use and manufactureSLOAN KETTERING INST CANCER·Filed 2015·Application pending·0 cites
- 2939US2019055592A1Nanopore Discrimination of Target Polynucleotides from Sample Background by Fragmentation and Payload BindingTWO PORE GUYS INC·Filed 2017·Application pending·0 cites
- 3039US2018363035A1Methods and Compositions for Target Detection in a Nanopore Using a Labelled Polymer ScaffoldTWO PORE GUYS INC·Filed 2016·Application pending·0 cites
- 3137US2014099726A1Device for characterizing polymersTWO PORE GUYS INC·Filed 2012·Application pending·0 cites
- 3236US2018023114A1Labile Linkers for Biomarker DetectionTWO PORE GUYS INC·Filed 2016·Application pending·0 cites
- 3334US2017074855A1Scaffold Data Storage and Target Detection in a Sample Using a NanoporeTWO PORE GUYS INC·Filed 2015·Application pending·0 cites
- 3434US2018328919A1Target modification for tracking and detectionTWO PORE GUYS INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Daniel A. Heller files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →